1 This is attributed to greater susceptibility of motor and proprioceptive nerve fibers to demyelination because ... to studies of patients with rare diseases. In an observer-blinded comparative ...

The UAB Center for Pediatric-Onset Demyelinating Disease (CPODD) is one of the founding Pediatric Multiple Sclerosis (MS) Centers of Excellence in the country designated and funded in 2006 by the ...

Chronic inflammatory demyelinating polyneuropathy (CIDP ... in CIDP because of the rarity and heterogeneity of the disease," ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic immune-mediated neuropathy. It affects peripheral nerves and roots. CIDP has no biomarkers. It may be monophasic ...

The importance of myelin is underscored by the presence of various diseases in which the primary problem is defective myelination. Demyelination is the condition in which preexisting myelin ...

Only subjects with at least 1 year of prior enrollment and no previous record of demyelinating disease were included. Each vaccinated subject was matched to three or four control subjects.

It is marketed under different proprietary names in other regions. Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare and serious autoimmune disease of the peripheral nervous system.

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...

PTD802 is a selective inhibitor of the GPR17 receptor and is made to restore myelin, a process known as remyelination, in ...

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...

Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...